Salvage radiotherapy with or without short-term hormone suppression for rising PSA levels
Gespeichert in:
| Veröffentlicht in: | Strahlentherapie und Onkologie 2016-10, Vol.192 (10), p.741-744 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | ger |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 744 |
|---|---|
| container_issue | 10 |
| container_start_page | 741 |
| container_title | Strahlentherapie und Onkologie |
| container_volume | 192 |
| creator | Hermann, R M Christiansen, H |
| description | |
| doi_str_mv | 10.1007/s00066-016-1032-6 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1825213415</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1825213415</sourcerecordid><originalsourceid>FETCH-LOGICAL-p141t-fc30c329952d6902122fdac9f7f4a5eef2f8c2524fd1dd8af4b3562a479e92383</originalsourceid><addsrcrecordid>eNo1kE1LAzEYhIMgtlZ_gBfJ0Us0X_uRYylahYJCFfS0pJs3bWR3sybZSv-9i9bTDMwzcxiErhi9ZZQWd5FSmueEspwwKjjJT9CUSaEIVep9gs5j_KRjKJU8QxNeZIIqwafoY62bvd4CDto4n3YQdH_A3y7tsA-_6oeE486HRBKEFo-u9R3gOPR9gBid77Ad0eCi67b4ZT3HDeyhiRfo1OomwuVRZ-jt4f518UhWz8unxXxFeiZZIrYWtBZcqYybXFHOOLdG18oWVuoMwHJb1jzj0hpmTKmt3Igs51oWChQXpZihm7_dPvivAWKqWhdraBrdgR9ixcqxzYRk2YheH9Fh04Kp-uBaHQ7V_x3iB6s3YXg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1825213415</pqid></control><display><type>article</type><title>Salvage radiotherapy with or without short-term hormone suppression for rising PSA levels</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Hermann, R M ; Christiansen, H</creator><creatorcontrib>Hermann, R M ; Christiansen, H</creatorcontrib><identifier>EISSN: 1439-099X</identifier><identifier>DOI: 10.1007/s00066-016-1032-6</identifier><identifier>PMID: 27530932</identifier><language>ger</language><publisher>Germany</publisher><subject>Adult ; Aged ; Androgen Antagonists - administration & dosage ; Chemoradiotherapy, Adjuvant - methods ; Chemoradiotherapy, Adjuvant - mortality ; Chemoradiotherapy, Adjuvant - utilization ; Combined Modality Therapy - methods ; Combined Modality Therapy - mortality ; France - epidemiology ; Humans ; Male ; Middle Aged ; Prevalence ; Prostate-Specific Antigen - blood ; Prostatectomy - mortality ; Prostatectomy - utilization ; Prostatic Neoplasms - blood ; Prostatic Neoplasms - mortality ; Prostatic Neoplasms - therapy ; Risk Factors ; Salvage Therapy - mortality ; Salvage Therapy - utilization ; Survival Rate ; Treatment Outcome</subject><ispartof>Strahlentherapie und Onkologie, 2016-10, Vol.192 (10), p.741-744</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27530932$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hermann, R M</creatorcontrib><creatorcontrib>Christiansen, H</creatorcontrib><title>Salvage radiotherapy with or without short-term hormone suppression for rising PSA levels</title><title>Strahlentherapie und Onkologie</title><addtitle>Strahlenther Onkol</addtitle><subject>Adult</subject><subject>Aged</subject><subject>Androgen Antagonists - administration & dosage</subject><subject>Chemoradiotherapy, Adjuvant - methods</subject><subject>Chemoradiotherapy, Adjuvant - mortality</subject><subject>Chemoradiotherapy, Adjuvant - utilization</subject><subject>Combined Modality Therapy - methods</subject><subject>Combined Modality Therapy - mortality</subject><subject>France - epidemiology</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prevalence</subject><subject>Prostate-Specific Antigen - blood</subject><subject>Prostatectomy - mortality</subject><subject>Prostatectomy - utilization</subject><subject>Prostatic Neoplasms - blood</subject><subject>Prostatic Neoplasms - mortality</subject><subject>Prostatic Neoplasms - therapy</subject><subject>Risk Factors</subject><subject>Salvage Therapy - mortality</subject><subject>Salvage Therapy - utilization</subject><subject>Survival Rate</subject><subject>Treatment Outcome</subject><issn>1439-099X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kE1LAzEYhIMgtlZ_gBfJ0Us0X_uRYylahYJCFfS0pJs3bWR3sybZSv-9i9bTDMwzcxiErhi9ZZQWd5FSmueEspwwKjjJT9CUSaEIVep9gs5j_KRjKJU8QxNeZIIqwafoY62bvd4CDto4n3YQdH_A3y7tsA-_6oeE486HRBKEFo-u9R3gOPR9gBid77Ad0eCi67b4ZT3HDeyhiRfo1OomwuVRZ-jt4f518UhWz8unxXxFeiZZIrYWtBZcqYybXFHOOLdG18oWVuoMwHJb1jzj0hpmTKmt3Igs51oWChQXpZihm7_dPvivAWKqWhdraBrdgR9ixcqxzYRk2YheH9Fh04Kp-uBaHQ7V_x3iB6s3YXg</recordid><startdate>201610</startdate><enddate>201610</enddate><creator>Hermann, R M</creator><creator>Christiansen, H</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201610</creationdate><title>Salvage radiotherapy with or without short-term hormone suppression for rising PSA levels</title><author>Hermann, R M ; Christiansen, H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p141t-fc30c329952d6902122fdac9f7f4a5eef2f8c2524fd1dd8af4b3562a479e92383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>ger</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Androgen Antagonists - administration & dosage</topic><topic>Chemoradiotherapy, Adjuvant - methods</topic><topic>Chemoradiotherapy, Adjuvant - mortality</topic><topic>Chemoradiotherapy, Adjuvant - utilization</topic><topic>Combined Modality Therapy - methods</topic><topic>Combined Modality Therapy - mortality</topic><topic>France - epidemiology</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prevalence</topic><topic>Prostate-Specific Antigen - blood</topic><topic>Prostatectomy - mortality</topic><topic>Prostatectomy - utilization</topic><topic>Prostatic Neoplasms - blood</topic><topic>Prostatic Neoplasms - mortality</topic><topic>Prostatic Neoplasms - therapy</topic><topic>Risk Factors</topic><topic>Salvage Therapy - mortality</topic><topic>Salvage Therapy - utilization</topic><topic>Survival Rate</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hermann, R M</creatorcontrib><creatorcontrib>Christiansen, H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Strahlentherapie und Onkologie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hermann, R M</au><au>Christiansen, H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Salvage radiotherapy with or without short-term hormone suppression for rising PSA levels</atitle><jtitle>Strahlentherapie und Onkologie</jtitle><addtitle>Strahlenther Onkol</addtitle><date>2016-10</date><risdate>2016</risdate><volume>192</volume><issue>10</issue><spage>741</spage><epage>744</epage><pages>741-744</pages><eissn>1439-099X</eissn><cop>Germany</cop><pmid>27530932</pmid><doi>10.1007/s00066-016-1032-6</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 1439-099X |
| ispartof | Strahlentherapie und Onkologie, 2016-10, Vol.192 (10), p.741-744 |
| issn | 1439-099X |
| language | ger |
| recordid | cdi_proquest_miscellaneous_1825213415 |
| source | MEDLINE; SpringerLink Journals |
| subjects | Adult Aged Androgen Antagonists - administration & dosage Chemoradiotherapy, Adjuvant - methods Chemoradiotherapy, Adjuvant - mortality Chemoradiotherapy, Adjuvant - utilization Combined Modality Therapy - methods Combined Modality Therapy - mortality France - epidemiology Humans Male Middle Aged Prevalence Prostate-Specific Antigen - blood Prostatectomy - mortality Prostatectomy - utilization Prostatic Neoplasms - blood Prostatic Neoplasms - mortality Prostatic Neoplasms - therapy Risk Factors Salvage Therapy - mortality Salvage Therapy - utilization Survival Rate Treatment Outcome |
| title | Salvage radiotherapy with or without short-term hormone suppression for rising PSA levels |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T03%3A41%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Salvage%20radiotherapy%20with%20or%20without%20short-term%20hormone%20suppression%20for%20rising%20PSA%20levels&rft.jtitle=Strahlentherapie%20und%20Onkologie&rft.au=Hermann,%20R%20M&rft.date=2016-10&rft.volume=192&rft.issue=10&rft.spage=741&rft.epage=744&rft.pages=741-744&rft.eissn=1439-099X&rft_id=info:doi/10.1007/s00066-016-1032-6&rft_dat=%3Cproquest_pubme%3E1825213415%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1825213415&rft_id=info:pmid/27530932&rfr_iscdi=true |